Clinical Trials Directory

Trials / Completed

CompletedNCT03126032

Early Detection of Glycocalyx Damage in Emergency Room Patients

Status
Completed
Phase
Study type
Observational
Enrollment
260 (actual)
Sponsor
University Hospital Muenster · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Aim of the study is to evaluate to what extent a glycocalyx damage measured in the ER in patients presenting with sepsis correlates with their clinical course and if it can be used as a clinical stratification tool and mortality predictor. The study will focus on the changes of the microcirculation and how they correlate with the macrocirculation, as well as microbiologic parameters. In the study will participate ca. 300 patients with sepsis, as well as 30 patients without sepsis and 30 healthy individuals.

Conditions

Interventions

TypeNameDescription
OTHERGlycoCheck™-SystemConsecutive, sublingual measurements of endothelial glycocalyx with GlycoCheck™-System will be obtained at presentation, as well as during the inpatient treatment of the patients with suspected sepsis. Blood sample will be drawn in all groups at time of assessment. Besides that, in patients with suspected sepsis blood samples will be drawn for further microbiologic and laboratory analysis at day 1 and day 7 of their hospital stay.

Timeline

Start date
2017-04-03
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2017-04-24
Last updated
2020-04-02

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03126032. Inclusion in this directory is not an endorsement.